Product information

From Health Canada

Current status:

Dormant

Current status date:

2017-06-22

Original market date: See footnote 1

1997-05-28

Product name:

RELEFACT TRH INJECTION 200MCG/ML

DIN:

02224615 Electronic product monograph is not available

Company:

ODAN LABORATORIES LTD
325 Stillview Avenue
Pointe-Claire
Quebec
Canada H9R 2Y6

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

36:60.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V04CJ02 PROTIRELIN

Active ingredient group (AIG) number:See footnote5

0111428001

List of active ingredient(s)
Active ingredient(s) Strength
PROTIRELIN 200 MCG / ML
Version 4.0.2
Date modified: